The anti-fibrotic effects of NO-GC in pulmonary fibrosis have already been postulated, as in vitro and in vivo findings indicate NO-GC to suppress TGFβ-mediated effects [25,26,27,28]. The gene discussed is TGFB1; the disease is pulmonary fibrosis.